| :30 second American Lung Association PSA - Video American Lung Association to “Fight for Air” in New Advertising feedproxy.google.com |
U.S. Eases Move to Electronic Medical Records The Obama administration loosened the rules for hospitals and doctors to qualify for federal funding to replace paper medical records with electronic files for patients. online.wsj.com |
The Salt Hiding in Your Diet Adults consume more salt than recommended. Now, officials want us to eat even less. That's easier said than done, in part because people often don't know it's in their food. online.wsj.com |
Regulators Sue Juice Maker POM The FTC sued POM Wonderful, maker of a popular pomegranate juice, alleging unsubstantiated health claims. online.wsj.com |
Jazz Feels No Pain Following FDA Rejection EP Vantage submits:Following the overwhelming negative FDA panel vote against Jazz Pharmaceuticals’ (JAZZ) fibromyalgia treatment JZP-6, the agency’s complete response letter did not come as a surprise. What may surprise is that Jazz shares have recovered nearly all their value since the advisory committee vote two months ago.Even as the FDA document asked for additional clinical work to clarify the safety of taking JZP-6, along with risk mitigation questions, Jazz shares were up 8% last week to $10.95 by close on Wednesday. This surprising behavior - just two months after shares fell more than one-fifth to $7.96 on the day following the adcom vote - likely reflects the fact that investors were holding out little real hope of the drug reaching the market, even before the advisory committee review. Investors appear to have moved on; it would not be surprising if the company now does the same by drawing a line under this project. Complete Story » seekingalpha.com |